Li, Q., Li, Y., Wang, Z., Pan, M., Liao, X. (2026). Phase I study of liposomal irinotecan plus fruquintinib as third- or later-line therapy for metastatic colorectal cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15571